Reuters logo
Bayer says discussing size of animal health unit
July 30, 2014 / 1:46 PM / 3 years ago

Bayer says discussing size of animal health unit

FRANKFURT, July 30 (Reuters) - German healthcare group Bayer is discussing internally whether its animal health unit needs to be bulked up to better compete with rivals, its chief executive said.

“We have a good animal health business but things are happening in the industry ... that make us take a look at the question to what extent is critical mass important in animal health,” CEO Marijn Dekkers told analysts in a conference call.

Dekkers pointed to Novartis’s decision in April to sell its animal health arm to Eli Lilly for about $5.4 billion and to Pfizer spinning off its animal health unit Zoetis last year as events that have changed the industry.

Bayer is the world’s fifth-largest veterinary drugs maker, based on 2013 sales of 1.3 billion euros ($1.7 billion).

$1 = 0.7477 Euros Reporting by Ludwig Burger

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below